Merck KGaA (FRA:MRK) has been given a €120.00 ($141.18) target price by research analysts at UBS AG in a report released on Monday, www.boersen-zeitung.de reports. The firm currently has a “buy” rating on the healthcare company’s stock.

A number of other research analysts have also commented on MRK. equinet AG set a €112.00 ($131.76) price objective on Merck KGaA and gave the company a “neutral” rating in a report on Monday, June 26th. Morgan Stanley set a €103.00 ($121.18) target price on Merck KGaA and gave the company a “neutral” rating in a report on Monday, June 26th. Independent Research GmbH set a €115.00 ($135.29) target price on Merck KGaA and gave the company a “neutral” rating in a report on Monday, June 26th. Nord/LB reaffirmed a “neutral” rating on shares of Merck KGaA in a report on Wednesday, June 28th. Finally, Warburg Research set a €116.00 ($136.47) target price on Merck KGaA and gave the company a “neutral” rating in a report on Friday, July 7th. Thirteen equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of €109.43 ($128.75).

Merck KGaA (MRK) traded down 0.60% during trading on Monday, reaching €93.58. The company’s stock had a trading volume of 732 shares. The firm has a market capitalization of €40.69 billion and a price-to-earnings ratio of 24.40. Merck KGaA has a 52-week low of €89.00 and a 52-week high of €115.00. The stock’s 50-day moving average is €95.92 and its 200 day moving average is €101.24.

WARNING: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/10/23/ubs-ag-analysts-give-merck-kgaa-mrk-a-120-00-price-target.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.